Adverse events following discharge from the hospital

Comment

. 2004 Feb 3;140(3):232; author reply 232-3.

doi: 10.7326/0003-4819-140-3-200402030-00021.

Comment

Rodney A Hayward et al. Ann Intern Med. 2004.

. 2004 Feb 3;140(3):232; author reply 232-3.

doi: 10.7326/0003-4819-140-3-200402030-00021.

No abstract available

Comment on

The incidence and severity of adverse events affecting patients after discharge from the hospital.
Forster AJ, Murff HJ, Peterson JF, Gandhi TK, Bates DW. Forster AJ, et al. Ann Intern Med. 2003 Feb 4;138(3):161-7. doi: 10.7326/0003-4819-138-3-200302040-00007. Ann Intern Med. 2003. PMID: 12558354

Adverse events following discharge from the hospital.
Medlock MM, Cantilena LR Jr, Riel MA. Medlock MM, et al. Ann Intern Med. 2004 Feb 3;140(3):231-2; author reply 232-3. doi: 10.7326/0003-4819-140-3-200402030-00020. Ann Intern Med. 2004. PMID: 14757626 No abstract available.
Adverse events occur after hospital discharge, study finds.
Traynor K. Traynor K. Am J Health Syst Pharm. 2003 Mar 15;60(6):534. doi: 10.1093/ajhp/60.6.534. Am J Health Syst Pharm. 2003. PMID: 12659052 No abstract available.
Introduction to the Special Section for Sources of Safety Data and Statistical Strategies for Design and Analysis.
Zink RC. Zink RC. Ther Innov Regul Sci. 2018 Mar;52(2):140. doi: 10.1177/2168479018760813. Ther Innov Regul Sci. 2018. PMID: 29714517 No abstract available.
Inclusion of placebos and blinding for ascending dose first-in-human studies and other underpowered phase 1 studies has not been justified and on balance is not useful.
Parasrampuria DA, Benet LZ. Parasrampuria DA, et al. Basic Clin Pharmacol Toxicol. 2015 Jul;117(1):44-51. doi: 10.1111/bcpt.12352. Epub 2014 Dec 23. Basic Clin Pharmacol Toxicol. 2015. PMID: 25406995 Review.
Adverse drug events and medication errors in Australia.
Runciman WB, Roughead EE, Semple SJ, Adams RJ. Runciman WB, et al. Int J Qual Health Care. 2003 Dec;15 Suppl 1:i49-59. doi: 10.1093/intqhc/mzg085. Int J Qual Health Care. 2003. PMID: 14660523 Review.